Wells Fargo & Company Coll Plant Biotechnologies LTD Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Wells Fargo & Company holds 8,405 shares of CLGN stock, worth $29,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,405
Previous 4,000
110.13%
Holding current value
$29,165
Previous $19,000
57.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
2.05MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD490KShares$1.7 Million0.03% of portfolio
-
Villere St Denis J & CO LLC484KShares$1.68 Million0.17% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.61 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$959,2122.69% of portfolio
-
Brown Advisory Inc119KShares$414,5430.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $38.5M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...